Evotec SE (ETR:EVT)
4.892
-0.148 (-2.94%)
Jul 8, 2026, 5:35 PM CET
Evotec SE Employees
Evotec SE had 4,526 employees as of March 31, 2026. The number of employees decreased by 240 or -5.04% compared to the same quarter last year.
Employees
4,526
Change
-240
Growth
-5.04%
Revenue / Employee
€164,613
Profits / Employee
€42,836
Market Cap
869.55M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 4,526 | -240 | -5.04% |
| Dec 31, 2025 | 4,467 | -273 | -5.76% |
| Sep 30, 2025 | 4,788 | -219 | -4.37% |
| Jun 30, 2025 | 4,759 | -263 | -5.24% |
| Mar 31, 2025 | 4,766 | -289 | -5.72% |
| Dec 31, 2024 | 4,740 | -321 | -6.34% |
| Sep 30, 2024 | 5,007 | -79 | -1.55% |
| Jun 30, 2024 | 5,022 | -45 | -0.89% |
| Mar 31, 2024 | 5,055 | 103 | 2.08% |
| Dec 31, 2023 | 5,061 | 109 | 2.20% |
| Sep 30, 2023 | 5,086 | 371 | 7.87% |
| Jun 30, 2023 | 5,067 | 546 | 12.08% |
| Dec 31, 2022 | 4,952 | 754 | 17.96% |
| Sep 30, 2022 | 4,715 | 634 | 15.54% |
| Jun 30, 2022 | 4,521 | 607 | 15.51% |
| Mar 31, 2022 | 4,354 | 619 | 16.57% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,783 |
| Bayer Aktiengesellschaft | 87,757 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 59,077 |
| RHÖN-KLINIKUM Aktiengesellschaft | 19,184 |
| Drägerwerk AG & Co. KGaA | 16,033 |
| Gerresheimer AG | 13,535 |
| Dermapharm Holding SE | 3,503 |
Evotec SE News
- 9 days ago - Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics - PRNewsWire
- 15 days ago - Evotec SE Proxy statement: Proxy filing - Filings
- 22 days ago - Evotec SE Slides: Company presentation - Filings
- 27 days ago - Evotec Reports Results of the Annual General Meeting 2026 - PRNewsWire
- 5 weeks ago - Evotec Appoints Rui Wang as Head of Global In Silico and AI - Accesswire
- 2 months ago - Evotec SE Successfully Placed €116.1 Million Convertible Bonds - Accesswire
- 2 months ago - Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall - Accesswire
- 2 months ago - Evotec Receives Grants to Advance Tuberculosis Treatment - Accesswire